Japan Varicella Vaccine Market Analysis

Japan Varicella Vaccine Market Analysis


$ 3999

Japan Varicella Vaccine Market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. Varicella Vaccine market is growing globally due to the increasing vaccination coverage, growing public awareness about varicella vaccination, well established safety and efficacy profile of varicella vaccine, launch of varicella control programs by various governments. Merck & Co., Inc., GlaxoSmithKline plc, Sanofi Pasteur, Pfizer Inc., Serum Institute of India Pvt. Ltd., Bharat Biotech International Ltd., Changchun BCHT Biotechnology Co., Ltd., Sinovac Biotech Ltd., Kaketsuken (Japan Blood Products Organization) and Shanghai Institute of Biological Products are the key global market players.

ID: IN10JPPH418 CATEGORY: Pharmaceuticals GEOGRAPHY: Japan AUTHOR: Vidhi Upadhyay

Buy Now

Japan Varicella Vaccine Market Analysis Summary

Japan Varicella Vaccine Market is valued at around $196.3 Mn in 2022 and is projected to reach $329.7 Mn by 2030, exhibiting a CAGR of 6.7% during the forecast period 2023-2030.

The varicella vaccine, also known as the chickenpox vaccine, is used to prevent varicella-zoster virus (VZV) infection, which causes chickenpox and shingles, or herpes zoster.

Chickenpox: Commonly affecting children, chickenpox is characterized by an all-over rash of itchy, fluid-filled blisters. Fever, exhaustion, headaches, and appetite loss are possible additional symptoms. It is quickly transferred by respiratory droplets or by coming into contact with the rash. The majority of chickenpox episodes are minor and self-limiting, but problems can happen, particularly in some high-risk populations like infants, pregnant women, and those with compromised immune systems. The varicella vaccine is highly effective in preventing chickenpox. It is usually administered in childhood as part of routine immunization schedules in many countries. Varicella Attenuated Live Vaccine contains a weakened form of the varicella-zoster virus that stimulates the immune system to produce a protective response. The vaccine is administered as a single-dose or a two-dose series. Varicella-zoster Vaccine or the shingles vaccine which contains a higher concentration of the varicella-zoster virus antigen compared to the varicella vaccine. It is recommended for individuals aged 50 and older to reduce the risk of developing shingles and its complications. Merck & Co., Inc., GlaxoSmithKline plc, Sanofi Pasteur, Pfizer Inc., Serum Institute of India Pvt. Ltd., Bharat Biotech International Ltd., Changchun BCHT Biotechnology Co., Ltd., Sinovac Biotech Ltd., Kaketsuken (Japan Blood Products Organization) and Shanghai Institute of Biological Products are the key global market players.

Market Dynamics

Market Growth Drivers

Increasing vaccination coverage, growing public awareness about varicella vaccination, well-established safety and efficacy profile of varicella vaccine, and launch of varicella control programs by various governments act as market growth drivers.

Market Restraints

Vaccine hesitancy due to misinformation about vaccine safety, cost and affordability barriers, cold chain requirements, and storage issues act as market growth restraints.

Competitive Landscape

Key Player

  • Merck & Co., Inc.
  • GlaxoSmithKline plc
  • Sanofi Pasteur
  • Pfizer Inc.
  • Serum Institute of India Pvt. Ltd.
  • Bharat Biotech International Ltd.
  • Changchun BCHT Biotechnology Co., Ltd.
  • Sinovac Biotech Ltd.
  • Kaketsuken (Japan Blood Products Organization)
  • Shanghai Institute of Biological Products

1. Executive Summary
1.1 Disease Overview
1.2 Global Scenario
1.3 Country Overview
1.4 Healthcare Scenario in Country
1.5 Patient Journey
1.6 Health Insurance Coverage in Country
1.7 Active Pharmaceutical Ingredient (API)
1.8 Recent Developments in the Country

2. Market Size and Forecasting
2.1 Epidemiology of Disease
2.2 Market Size (With Excel & Methodology)
2.3 Market Segmentation (Check all Segments in Segmentation Section)

3. Market Dynamics
3.1 Market Drivers
3.2 Market Restraints

4. Competitive Landscape
4.1 Major Market Share

4.2 Key Company Profile (Check all Companies in the Summary Section)

4.2.1 Company
4.2.1.1 Overview
4.2.1.2 Product Applications and Services
4.2.1.3 Recent Developments
4.2.1.4 Partnerships Ecosystem
4.2.1.5 Financials (Based on Availability)

5. Reimbursement Scenario
5.1 Reimbursement Regulation
5.2 Reimbursement Process for Diagnosis
5.3 Reimbursement Process for Treatment

6. Methodology and Scope

Market Segmentations For Japan Varicella Vaccine Market

By Vaccine type

  • Varicella Attenuated Live Vaccine
  • Varicella-zoster Vaccine (Shingles Vaccine)

By End Users

  • Pediatric Population
  • Adult Population

By Distribution Channels

  • Hospitals and Clinics
  • Retail Pharmacies

Methodology for Database Creation

Our database offers a comprehensive list of healthcare centers, meticulously curated to provide detailed information on a wide range of specialties and services. It includes top-tier hospitals, clinics, and diagnostic facilities across 30 countries and 24 specialties, ensuring users can find the healthcare services they need.​

Additionally, we provide a comprehensive list of Key Opinion Leaders (KOLs) based on your requirements. Our curated list captures various crucial aspects of the KOLs, offering more than just general information. Whether you're looking to boost brand awareness, drive engagement, or launch a new product, our extensive list of KOLs ensures you have the right experts by your side. Covering 30 countries and 36 specialties, our database guarantees access to the best KOLs in the healthcare industry, supporting strategic decisions and enhancing your initiatives.

How Do We Get It?

Our database is created and maintained through a combination of secondary and primary research methodologies.

1. Secondary Research

With many years of experience in the healthcare field, we have our own rich proprietary data from various past projects. This historical data serves as the foundation for our database. Our continuous process of gathering data involves:

  • Analyzing historical proprietary data collected from multiple projects.
  • Regularly updating our existing data sets with new findings and trends.
  • Ensuring data consistency and accuracy through rigorous validation processes.

With extensive experience in the field, we have developed a proprietary GenAI-based technology that is uniquely tailored to our organization. This advanced technology enables us to scan a wide array of relevant information sources across the internet. Our data-gathering process includes:

  • Searching through academic conferences, published research, citations, and social media platforms
  • Collecting and compiling diverse data to build a comprehensive and detailed database
  • Continuously updating our database with new information to ensure its relevance and accuracy

2. Primary Research

To complement and validate our secondary data, we engage in primary research through local tie-ups and partnerships. This process involves:

  • Collaborating with local healthcare providers, hospitals, and clinics to gather real-time data.
  • Conducting surveys, interviews, and field studies to collect fresh data directly from the source.
  • Continuously refreshing our database to ensure that the information remains current and reliable.
  • Validating secondary data through cross-referencing with primary data to ensure accuracy and relevance.

Combining Secondary and Primary Research

By integrating both secondary and primary research methodologies, we ensure that our database is comprehensive, accurate, and up-to-date. The combined process involves:

  • Merging historical data from secondary research with real-time data from primary research.
  • Conducting thorough data validation and cleansing to remove inconsistencies and errors.
  • Organizing data into a structured format that is easily accessible and usable for various applications.
  • Continuously monitoring and updating the database to reflect the latest developments and trends in the healthcare field.

Through this meticulous process, we create a final database tailored to each region and domain within the healthcare industry. This approach ensures that our clients receive reliable and relevant data, empowering them to make informed decisions and drive innovation in their respective fields.

To request a free sample copy of this report, please complete the form below.


We value your inquiry and offer free customization with every report to fulfil your exact research needs.


Last updated on: 27 February 2024
Updated by: Ritu Baliya

Related reports (by category)


Related reports (by geography)


subscribe to our newsletter
up